ESR1 and breast cancer: Qi and colleagues [70] assess the immune response, disease progression, and post-treatment survival of ER/PR double-negative stage II/IIIA BC patients vaccinated with autologous dendritic cells (DC) pulsed with autologous tumor lysates.